| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/30/2002 | US6380398 Compounds such as (s,s)1-(2-amino-3,3-dimethyl-butyryl)-2,5-dihydro-1h-pyrrole-2 -carbonitrile administered as antidiabetic agents; dipeptidyl peptidase-iv (dpp-iv) |
| 04/30/2002 | US6380395 Anticancer agents |
| 04/30/2002 | US6380394 Anticancer agents |
| 04/30/2002 | US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 04/30/2002 | US6380246 For combating pests and weeds |
| 04/30/2002 | US6380241 For therapy of coronary angina, cerebral vasospasm, acute and chronic renal failure, gastric ulceration, cyclosporin-induced nephrotoxicity, endotoxin-induced toxicity, asthma, lpl-related lipoprotein disorders, proliferative diseases |
| 04/30/2002 | US6380230 For therapy of dyskinesia, obesity, irritable bowel syndrome, diseases whose treatment requires stimulation of the cholecystokinin cck-a receptors |
| 04/30/2002 | US6380229 Useful for therapy and prophylaxis of hyperlipidemia and related complications |
| 04/30/2002 | US6380225 Microbicidal benzotriazoles |
| 04/30/2002 | US6380221 Ortho-anthranilamide derivatives as anti-coagulants |
| 04/30/2002 | US6380218 For therapy of respiratory, allergic, and inflammatory disorders comprising asthma, chronic obstructive pulmonary disease, acute respiratory disease syndrome, pulmonary hypersensitivity, and allergic rhinitis in a mammal |
| 04/30/2002 | US6380214 Thiophene-3-carboxylic acid amide derivatives |
| 04/30/2002 | US6380213 Compounds useful as neuro-protective agents |
| 04/30/2002 | US6380205 2-cyclohexyl quinazoline NMDA/NR2B antagonists |
| 04/30/2002 | US6380204 Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist activity |
| 04/30/2002 | US6380189 2-amino benzoxazinones for the treatment of viral infections |
| 04/30/2002 | US6380186 Psychotherapeutic agents |
| 04/30/2002 | US6380180 Potassium channel blocking agents |
| 04/30/2002 | US6379823 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye |
| 04/25/2002 | WO2002032900A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 04/25/2002 | WO2002032897A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 04/25/2002 | WO2002032894A1 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 04/25/2002 | WO2002032893A2 Piperidine compounds as anti-allergic |
| 04/25/2002 | WO2002032891A1 Flavan compounds, their preparation and their use in therapy |
| 04/25/2002 | WO2002032889A1 Aromatic and heterocyclic thiazolyl thiourea compounds and use |
| 04/25/2002 | WO2002032886A1 A process for the preparation of bis-benzazolyl compounds |
| 04/25/2002 | WO2002032872A1 Nitrogenous aromatic ring compounds |
| 04/25/2002 | WO2002032844A2 Epothilone synthesis components iii and iv: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone b, d and epothilone derivatives |
| 04/25/2002 | WO2002032422A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | WO2002010137A3 Indazole derivatives as JNK inhibitors |
| 04/25/2002 | WO2001081341A3 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations |
| 04/25/2002 | WO2001058891A3 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
| 04/25/2002 | WO2001002369A3 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 04/25/2002 | US20020049330 Such as 5-(N,N-dibenzyl)aminocarbonyl-2-pyridone; enzyme inhibitors; for treatment of Alzheimer's disease |
| 04/25/2002 | US20020049329 Novel human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 04/25/2002 | US20020049316 Protease inhibitors |
| 04/25/2002 | US20020049246 Benzimidazole compounds for treatment of asthma, vasospasm, memory loss, migraine and others diseases associated with potassium channels |
| 04/25/2002 | US20020049240 Novel compounds |
| 04/25/2002 | US20020049239 Novel indole and benzothiazole derivatives |
| 04/25/2002 | US20020049231 S(-)-3-aminothalidomide; treating wide variety of diseases including diabetic retinopathy |
| 04/25/2002 | US20020049223 Quinoline and naphthyridine carboxylic acid antibacterials |
| 04/25/2002 | US20020049214 Aralkyl and aralkylidene heterocyclic lactams and imides as selective agonists and antagonists of serotonin 1 (5-HT1) recepor, used in treating hypertension and all forms of depression |
| 04/25/2002 | US20020049210 Heteroaryl amines as novel acetylcholinesterase inhibitors |
| 04/25/2002 | US20020049204 1,4-dihydro-benzo(d)oxazin-2-one derivatives useful for treating hormone-dependent neoplastic disease is selected from uterine myometrial fibroids, endometriosis, benign prostatic hypertrophy, carcinomas, and adenocarcinoma |
| 04/25/2002 | US20020049201 Sulfonamide inhibitors of aspartyl protease |
| 04/25/2002 | US20020049195 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc. |
| 04/25/2002 | US20020049194 A benzoazepin or benzodiazepin derivatives, shows excellent anti-vasopressin activity, vasopressin agonistic activity and oxytocin antagonistic activity, and are useful as antagonist |
| 04/25/2002 | US20020049193 Inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity. |
| 04/25/2002 | US20020049142 Fungicidal, insecticidal, acaricidal, molluscicidal or nematicidal composition |
| 04/25/2002 | US20020048271 Methods and composition for restoring conformational stability of a protein of the p53 family |
| 04/25/2002 | CA2426487A1 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | CA2426337A1 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 04/25/2002 | CA2426148A1 Aromatic and heterocyclic thiazolyl thiourea compounds and use |
| 04/25/2002 | CA2423792A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 04/24/2002 | EP1199307A1 Pharmaceutically active benzoquinazoline compounds |
| 04/24/2002 | EP1199306A1 Biarylurea derivatives |
| 04/24/2002 | EP0714299B1 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
| 04/24/2002 | CN1346355A Novel inhibitors of farnesyl-protein transferase |
| 04/24/2002 | CN1346354A Substituted benzoylpyrazoles as herbicides |
| 04/24/2002 | CN1346351A 1,2-benzothiazepines for the treatment of hyperlipidemic diseases |
| 04/24/2002 | CN1346350A Compound which inhibiti leukocyte adhesion mediated by VLA-4 |
| 04/24/2002 | CN1346282A Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as combination therapy method in treating neoplasia |
| 04/24/2002 | CN1346271A Quinazoline derivatives as angiogenesis inhibitors |
| 04/24/2002 | CN1083446C Process for preparing 2-chlorothiazole compounds |
| 04/24/2002 | CN1083431C Novel heterocyclic compounds |
| 04/23/2002 | US6376675 Pyridyl-1,2,5-thiadiazole derivatives |
| 04/23/2002 | US6376665 Antiarthritic agents, antiinflammatory agents |
| 04/23/2002 | US6376507 NK-1 receptor antagonists for the treatment of neuronal injury and stroke |
| 04/23/2002 | US6376503 Alpha 1a adrenergic receptor antagonists |
| 04/23/2002 | US6376491 Benzofuran derivatives for treatment or prevention of mycosis in mammals |
| 04/23/2002 | US6376490 Strong n-methyl-d-asparate receptor antagonists; useful in treating strokes, ischemia, and central nervous system injuries |
| 04/23/2002 | US6376487 Oxadiazine derivatives |
| 04/23/2002 | US6376484 For prevention and/or treatment of various kinds of inflammatory disease |
| 04/23/2002 | CA2246727C Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 04/18/2002 | WO2002030927A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same |
| 04/18/2002 | WO2002030926A1 Quinazoline derivatives |
| 04/18/2002 | WO2002030923A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 04/18/2002 | WO2002030895A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-η BINDING AGENTS |
| 04/18/2002 | WO2002030890A1 Nitrogenous five-membered ring compounds |
| 04/18/2002 | WO2002030886A2 Heterocyclic angiogenesis inhibitors |
| 04/18/2002 | WO2002030867A2 Drugs for diabetes |
| 04/18/2002 | WO2002030358A2 Modulation of ccr4 function |
| 04/18/2002 | WO2002030357A2 Compounds and methods for modulating ccr4 function |
| 04/18/2002 | WO2002030356A2 Synthesis of epothilones and relates analogs |
| 04/18/2002 | WO2002012210A9 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 04/18/2002 | WO2002008217A3 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS |
| 04/18/2002 | WO2001091732A3 Medicament for combating respiratory depression |
| 04/18/2002 | WO2001087830A3 Substituted thioacetamides |
| 04/18/2002 | WO2001058893A3 Indol-3-yl derivatives and their use as integrin inhibitors |
| 04/18/2002 | WO2001026656A3 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors |
| 04/18/2002 | US20020045654 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
| 04/18/2002 | US20020045652 Prophylactic or therapeutic drug for renal diseases |
| 04/18/2002 | US20020045647 N-linked urea or carbamate of heterocyclic thioester hair growth compositons and uses |
| 04/18/2002 | US20020045642 Antiinflammatory, -arthritic and -emetic agents; central nervous system disorders; Parkinson's disease; antidepressants; psychological disorders; anxiolytic agents; antagonists of substance P receptors |
| 04/18/2002 | US20020045641 Multiple heteroatom containing heterocyclic ring compounds substituted with carboxylic acids and isosteres thereof |
| 04/18/2002 | US20020045629 Sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators |
| 04/18/2002 | US20020045620 Readily metabolized by the metabolic drug detoxification systems; metabolized by serum or intracellular hydrolases and esterases; shorthalf-life; noninsulin-dependent diabetes mellitus (NIDDM) (Type II); side effect reduction |
| 04/18/2002 | US20020045618 Heteroaryl diazacycloalkanes, their preparation and use |
| 04/18/2002 | US20020045615 Benzothiazole derivatives with activity as adenosine receptor ligands |
| 04/18/2002 | US20020045609 Epothilone derivatives and methods for making and using the same |